Loading clinical trials...
Loading clinical trials...
A Study to Evaluate the Efficacy and Safety of 15mg BID Losmapimod (GW856553) Compared to Placebo in Frequently Exacerbating Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Conditions
Interventions
Losmapimod tablets
Placebo tablets
+1 more
Locations
36
Argentina
GSK Investigational Site
Buenos Aires, Argentina
GSK Investigational Site
Mendoza, Argentina
GSK Investigational Site
Mendoza, Argentina
GSK Investigational Site
San Miguel de Tucumán, Argentina
GSK Investigational Site
São Paulo, Brazil
GSK Investigational Site
Dimitrovgrad, Bulgaria
Start Date
December 9, 2014
Primary Completion Date
June 30, 2016
Completion Date
June 30, 2016
Last Updated
August 6, 2018
NCT06712563
NCT07518472
NCT06831994
NCT05730088
NCT02755974
NCT07363980
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions